These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 25684279)

  • 1. Safety of live attenuated influenza vaccine in atopic children with egg allergy.
    Turner PJ; Southern J; Andrews NJ; Miller E; Erlewyn-Lajeunesse M;
    J Allergy Clin Immunol; 2015 Aug; 136(2):376-81. PubMed ID: 25684279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study.
    Turner PJ; Southern J; Andrews NJ; Miller E; Erlewyn-Lajeunesse M;
    BMJ; 2015 Dec; 351():h6291. PubMed ID: 26645895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma.
    Turner PJ; Fleming L; Saglani S; Southern J; Andrews NJ; Miller E;
    J Allergy Clin Immunol; 2020 Apr; 145(4):1157-1164.e6. PubMed ID: 31863808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine.
    Gagnon R; Primeau MN; Des Roches A; Lemire C; Kagan R; Carr S; Ouakki M; Benoît M; De Serres G;
    J Allergy Clin Immunol; 2010 Aug; 126(2):317-23. PubMed ID: 20579720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events associated with intranasal influenza vaccine in the United States.
    Vasu N; Ghaffari G; Craig ET; Craig TJ
    Ther Adv Respir Dis; 2008 Aug; 2(4):193-8. PubMed ID: 19124371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordination of multidisciplinary resources for vaccination of egg-allergic individuals during an H1N1 (novel) influenza pandemic.
    Pien GC; LeBenger KS; Carotenuto DR; Difilippi M; Scolpino D; Simmons JM; Barrett C; Brenner RW
    Allergy Asthma Proc; 2010; 31(6):507-10. PubMed ID: 20943012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
    Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP
    Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Egg allergy and influenza vaccination.
    Settipane RA; Siri D; Bellanti JA
    Allergy Asthma Proc; 2009; 30(6):660-5. PubMed ID: 20031013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing.
    Ambrose CS; Dubovsky F; Yi T; Belshe RB; Ashkenazi S
    Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2549-57. PubMed ID: 22410646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh.
    Ortiz JR; Goswami D; Lewis KD; Sharmeen AT; Ahmed M; Rahman M; Rahman MZ; Feser J; Neuzil KM; Brooks WA
    Vaccine; 2015 Jun; 33(29):3415-21. PubMed ID: 25917680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safe administration of the seasonal trivalent influenza vaccine to children with severe egg allergy.
    Greenhawt MJ; Spergel JM; Rank MA; Green TD; Mansoor D; Sharma H; Bird JA; Chang JE; Parikh DS; Teich E; Kelso JM; Sanders GM
    Ann Allergy Asthma Immunol; 2012 Dec; 109(6):426-30. PubMed ID: 23176882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.
    Baxter R; Eaton A; Hansen J; Aukes L; Caspard H; Ambrose CS
    Vaccine; 2017 Mar; 35(9):1254-1258. PubMed ID: 28162825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administering influenza vaccine to egg-allergic persons.
    Kelso JM
    Expert Rev Vaccines; 2014 Aug; 13(8):1049-57. PubMed ID: 24962036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live attenuated influenza vaccine use and safety in children and adults with asthma.
    Duffy J; Lewis M; Harrington T; Baxter R; Belongia EA; Jackson LA; Jacobsen SJ; Lee GM; Naleway AL; Nordin J; Daley MF;
    Ann Allergy Asthma Immunol; 2017 Apr; 118(4):439-444. PubMed ID: 28390584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy.
    Esposito S; Gasparini C; Martelli A; Zenga A; Tremolati E; Varin E; Marseglia GL; Fiocchi A; Principi N
    Vaccine; 2008 Aug; 26(36):4664-8. PubMed ID: 18639601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of live-attenuated influenza vaccination in cystic fibrosis.
    Boikos C; De Serres G; Lands LC; Boucher FD; Tapiéro B; Daigneault P; Quach C
    Pediatrics; 2014 Oct; 134(4):e983-91. PubMed ID: 25225145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial.
    Gaglani MJ; Piedra PA; Riggs M; Herschler G; Fewlass C; Glezen WP
    Pediatr Infect Dis J; 2008 May; 27(5):444-52. PubMed ID: 18401289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009-2010 season.
    Tennis P; Toback SL; Andrews EB; McQuay LJ; Ambrose CS
    Vaccine; 2012 Sep; 30(42):6099-102. PubMed ID: 22841479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of food challenges to extensively heated egg in egg-allergic children: a prospective cohort study.
    Turner PJ; Mehr S; Joshi P; Tan J; Wong M; Kakakios A; Campbell DE
    Pediatr Allergy Immunol; 2013 Aug; 24(5):450-5. PubMed ID: 23773122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study.
    Daley MF; Clarke CL; Glanz JM; Xu S; Hambidge SJ; Donahue JG; Nordin JD; Klein NP; Jacobsen SJ; Naleway AL; Jackson ML; Lee G; Duffy J; Weintraub E
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):59-68. PubMed ID: 29148124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.